Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Pfizer
Company Monitoring Page for Pfizer
latest headlines for company on cafepharma
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Tags:
Synnovation Therapeutics
,
Incyte
,
AstraZeneca
,
GSK
,
Novartis
,
Pfizer
,
funding
,
cancer
,
PARP inhibitors
Ex-Pfizer employee convicted of insider trading on COVID drug trial
Reuters
Thu, 01/18/24 - 04:50 pm
Tags:
Pfizer
,
insider trading
,
COVID-19
,
clinical trials
BridgeBio taps investors for $1.25B to fund showdown with Pfizer
Fierce Biotech
Thu, 01/18/24 - 11:00 am
Tags:
BridgeBio
,
Pfizer
,
funding
,
ATTR
JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals
Fierce Pharma
Thu, 01/11/24 - 11:34 am
Tags:
Pfizer
,
oncology
,
cancer
,
antibody-drug conjugate
,
JPMHC 2024
Pfizer to remain aggressive on obesity market after setback
Reuters
Mon, 01/8/24 - 10:19 pm
Tags:
Pfizer
,
Albert Bourla
,
Pharma CEOs
,
JPMHC 2024
,
obesity
After Pfizer's exit, UCB splits from industry trade group BIO
Fierce Pharma
Sun, 01/7/24 - 04:20 pm
Tags:
UCB Pharma
,
BIO
,
Pfizer
Pfizer rings in New Year with hemophilia B gene therapy nod in Canada
Fierce Pharma
Wed, 01/3/24 - 05:10 pm
Tags:
Pfizer
,
Canada
,
gene therapy
,
hemophilia B
,
Beqvez
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
Tags:
clinical trials
,
Beam Therapeutics
,
Moderna Therapeutics
,
Pfizer
,
Sanofi
,
Gilead Sciences
,
JNJ
,
Amylx
,
Roche
,
Alnylam Pharmaceuticals
,
Vertex Pharmaceuticals
Millions of doses of Pfizer's Paxlovid will go to waste in UK, EU as COVID demand plummets
Fierce Pharma
Tue, 01/2/24 - 10:08 pm
Tags:
Pfizer
,
Paxlovid
,
COVID-19
,
antivirals
2023 drug approvals: After a down year, FDA signs off on a bounty of new meds, including 7 from Pfizer
Fierce Pharma
Tue, 01/2/24 - 10:10 am
Tags:
FDA
,
drug approvals
,
Pfizer
,
COVID-19
Drugmakers set to raise US prices on at least 500 drugs in January
Reuters
Tue, 01/2/24 - 09:59 am
Tags:
drug pricing
,
Pfizer
,
Sanofi
,
Takeda
Pfizer's Hospira recall spree bleeds into 2024 with product pulls for multiple hospital drugs in shortage
Fierce Pharma
Wed, 12/27/23 - 11:12 pm
Tags:
Pfizer
,
Hospira
,
injectibles
,
product recalls
Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer
Fierce Pharma
Tue, 12/19/23 - 10:26 am
Tags:
Merck
,
Astellas
,
Pfizer
,
Keytruda
,
Padcev
,
bladder cancer
Should You Worry About the Latest Wave of Bad News from Pfizer?
Motley Fool
Sun, 12/17/23 - 09:52 pm
Tags:
Pfizer
,
COVID-19
Pfizer Inks Potential $1B ADC Deal with Nona, Closes Seagen Acquisition
BioSpace
Fri, 12/15/23 - 11:35 am
Tags:
Pfizer
,
Nona Biosciences
,
M&A
,
Seagen
,
solid tumors
Pfizer donates rights to cancer drug
Beckers Hospital Review
Wed, 12/13/23 - 09:39 am
Tags:
Pfizer
,
Bavencio
,
AACR
,
cancer
Pfizer shares sink as COVID revenue expectations wane
Reuters
Wed, 12/13/23 - 09:33 am
Tags:
Pfizer
,
COVID-19
Pfizer’s $43B Seagen Buy Clears Regulatory Hurdles, Plans Dec 14 Closing
BioSpace
Wed, 12/13/23 - 09:32 am
Tags:
Pfizer
,
Seagen
,
M&A
Pfizer reveals reorganization, executive departure as it gets ready to close $43B Seagen buyout
Fierce Pharma
Tue, 12/12/23 - 11:23 am
Tags:
Pfizer
,
Seagen
,
M&A
,
reorganization
ASH: Pfizer, swimming in crowded waters, eyes wide impact for sickle cell, hemophilia assets
Fierce Biotech
Sun, 12/10/23 - 11:12 pm
Tags:
Pfizer
,
sickle cell disease
,
ASH
,
marstacimab
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.